Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration

• Main Authors: Jenna M. Faircloth (Author), Neelam D. Bhatt (Author), Corey A. Chartan (Author), Ryan D. Coleman (Author), Natalie Villafranco (Author), Fadel E. Ruiz (Author), Raysa Morales-Demori (Author), Elise Whalen (Author), Erin Ely (Author), Rozmeen Fombin (Author), Nidhy P. Varghese (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Selexipag, a selective prostacyclin receptor agonist, is approved for treating pulmonary arterial hypertension in WHO Group 1 adult patients. Compared to parenteral prostacyclin formulations, selexipag offers a significant improvement in patient's and caregiver's quality of life because of...